|
| 1 | +## Consumable Availability Scenarios |
| 2 | + |
| 3 | +This README describes the different **scenarios** used in consumable availability analysis. Each scenario corresponds to a specific level of availability of consumables across health facilities and months. The data for these scenarios are stored in columns such as `available_prop_scenario1`, `available_prop_scenario2`, etc., in the `ResourceFile_Consumables_availability_small.csv`. This is generated by the the following scripts - 1. `consumable_availability_estimation.py` generates the `available_prop` column representing the proportion of instances that a consumables is likely to be available given the levels of availability observed during 2018, 2. `generate_consumable_availability_scenarios_for_impact_analysis.py` generates additional scenarios of consumable availability ans appends them to the file generated by the first script. |
| 4 | + |
| 5 | +The scenario names below can be specified as parameters for `cons_availability` under `HealthSystem` when running simulations. |
| 6 | + |
| 7 | +--- |
| 8 | + |
| 9 | +### **Base Scenario** |
| 10 | +- `default` |
| 11 | + - **Description:** Actual 2018 availability estimates based on OpenLMIS data. |
| 12 | + - **Purpose:** Serves as the baseline for comparisons. |
| 13 | + |
| 14 | +--- |
| 15 | + |
| 16 | +### **Scenarios 1–5: System-Level Improvements at Level 1a + 1b ** |
| 17 | +These are based on regression analysis performed in [Mohan et al (2024)](https://pubmed.ncbi.nlm.nih.gov/38762283/). |
| 18 | + |
| 19 | +| Scenario | Column Name | Description | |
| 20 | +|----------|---------------------------|-------------| |
| 21 | +| 1 | `scenario1` | All items perform like *non-drug/diagnostic* consumables. | |
| 22 | +| 2 | `scenario2` | Scenario 1 + all items match performance of *vital* medicines. | |
| 23 | +| 3 | `scenario3` | Scenario 2 + all facilities match those managed by *pharmacists*. | |
| 24 | +| 4 | `scenario4` | Scenario 3 + Level 1a facilities perform like Level 1b. | |
| 25 | +| 5 | `scenario5` | Scenario 4 + All facilities perform like *CHAM* facilities. | |
| 26 | + |
| 27 | +--- |
| 28 | + |
| 29 | +### **Scenarios 6–9: Benchmarking Against Best Facilities** |
| 30 | +| Scenario | Column Name | Description | |
| 31 | +|----------|---------------------------|-------------| |
| 32 | +| 6 | `scenario6` | All Level 1a/1b facilities match the *75th percentile* facility for each item. | |
| 33 | +| 7 | `scenario7` | Same as above but using the *90th percentile*. | |
| 34 | +| 8 | `scenario8` | Same as above but using the *99th percentile*. | |
| 35 | +| 9 | `scenario9` | Level 1a, 1b, and 2 facilities match the *99th percentile*. | |
| 36 | + |
| 37 | +--- |
| 38 | + |
| 39 | +### **Scenarios 10–11: Horizontal Supply Chain Alignment** |
| 40 | +| Scenario | Column Name | Description | |
| 41 | +|----------|---------------------------|-------------| |
| 42 | +| 10 | `scenario10` | All programs perform as well as *HIV* programs (only levels 1a and 1b updated). | |
| 43 | +| 11 | `scenario11` | All programs perform as well as *EPI* programs (only levels 1a and 1b updated). | |
| 44 | + |
| 45 | +Scenarios 6-8 and 10-11 only include levels 1a and 1b where most of the service is delivered and consumable availability is particularly a challenge to match up with the regression-analysis-based scenarios 1-5 |
| 46 | + |
| 47 | +--- |
| 48 | + |
| 49 | +### **Scenarios 12–15: HIV Drug Supply Adjustments** |
| 50 | +| Scenario | Column Name | Description | |
| 51 | +|----------|---------------------------|-------------| |
| 52 | +| 12 | `scenario12` | HIV performs as well (i.e. as badly) as general programs (excluding EPI and Cancer), benchmarked at *Facility_Level*. | |
| 53 | +| 13 | `scenario13` | HIV performs as well as other programs, benchmarked at *Facility_ID*. | |
| 54 | +| 14 | `scenario14` | Same as Scenario 13, but availability scaled *up* by 25%. | |
| 55 | +| 15 | `scenario15` | Same as Scenario 13, but availability scaled *down* by 25%. | |
| 56 | + |
| 57 | +--- |
| 58 | + |
| 59 | +### **Upper Bound Scenario** |
| 60 | +- **`all`** |
| 61 | + - **Description:** All consumables are always available (i.e., 100% availability). |
| 62 | + - **Purpose:** Represents the theoretical upper bound for health gains due to supply improvements. |
| 63 | + |
| 64 | +--- |
| 65 | + |
0 commit comments